-
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trialLopes RD, Vora AN, Liaw D et al. -
Switching P2Y12-receptor inhibitors in patients with coronary artery diseaseRollini F, Franchi F, Angiolillo DJ.
-
Homeostatic Chemokines and Prognosis in Patients With Acute Coronary SyndromesKC, M Hartford, A Ravn-Fischer, E Lorentzen et al.
-
Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic ShockA Lemor, MB Basir, and on behalf of the National Cardiogenic Shock Initiative Investigators.
-
Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-studyNaber CK, Urban P, LEADERS FREE Investigators et al.
-
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art ReviewEB Wu , ES Brilakis, K Mashayekhi et al.
-
Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological InsightsC Haig, D Carrick, J Carberry et al.
-
Percutaneous Support Devices for Percutaneous Coronary InterventionPatel MR.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
